APLNR inhibited nasopharyngeal carcinoma growth and immune escape by downregulating PD-L1.
Liu Y, Li N, Guo Y, Zhou Q, Yang Y, Lu J, Tian Z, Zhou J, Yan S, Li X, Shi L, Jiang S, Ge J, Feng R, Huang D, Zeng Z, Fan S, Xiong W, Li G, Zhang W.
Liu Y, et al. Among authors: zhou j.
Int Immunopharmacol. 2024 Jun 21;137:112523. doi: 10.1016/j.intimp.2024.112523. Online ahead of print.
Int Immunopharmacol. 2024.
PMID: 38909500